Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...

Some doctors say the chemicals all around us may be increasing our risk of Parkinson’s disease, the fastest-growing ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

For neurologist and movement disorder specialist Dr. Jill Giordano Farmer, the fight against Parkinson’s isn’t just ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

What happens in the brain when a person experiences the characteristic movement symptoms of Parkinson's disease? Researchers ...

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...

Parkinson's disease is fundamentally a breakdown in the functioning of a part of the brain called the basal ganglia, robbing ...

Parkinson's disease (PD) is a widespread neurological ailment that is becoming more prevalent as the world's population ages. It is estimated that approximately 10 million people worldwide are ...

For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...

Skin conditions with Parkinson’s disease are common and manageable. By paying attention to these symptoms, patients can ...